FIELD: chemistry.
SUBSTANCE: invention relates to versions of an improved method for synthesis of 5-(methyl-1H-imidazol-1-yl)-3-(trifluoromethyl) benzamide of formula (I), for example compound (1a). The obtained compounds can be used to treat neoplastic diseases such as leukaemia. The method involves reaction of a compound of formula (II)
,
with 5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)benzamine of formula (IVa):
, .
R1 denotes 5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl; R2 denotes hydrogen; R4 denotes hydrogen, lower alkyl or halogen; and R3 denotes lower alkyl, phenyl, phenyl-lower alkyl or substituted phenyl. The reaction takes place in an organic solvent in the presence of a base as a catalyst, selected from a group comprising a metal hydride, (volumetric) alkyllithium, metal alkoxide, metal bis-(trimethylsilyl)amide and lithium dialkylamide.
EFFECT: method simplifies synthesis of desired products by excluding expensive compounds and obtaining products with stable high output.
5 cl, 4 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING PROLIFERATIVE DISORDERS AND OTHER PATHOLOGICAL CONDITIONS MEDIATED BY ACTIVITY OF KINASE BCR-ABL, C-KIT, DDR1, DDR2 OR PDGF-R | 2010 |
|
RU2625835C2 |
DIKETONE AS INTERMEDIATE FOR 3-HALOGENE-1H-PYRASOLES | 1996 |
|
RU2251543C2 |
ANTHRANILIC ACID AND THIOANTHRANILIC ACID N-ARYLAMIDES | 1999 |
|
RU2286338C2 |
METHOD OF PREPARING 3-HALOGENALKYL-1H- PYRAZOLES | 1996 |
|
RU2169143C2 |
COMBINATION, INCLUDING A) PYRIMIDYLAMINOBENZAMIDE AND B) KINASE Thr315lle INHIBITOR | 2007 |
|
RU2481840C2 |
TYROSINE KINASE INHIBITORS | 2008 |
|
RU2445309C2 |
DERIVATIVES OF 2-AMINONICOTINE AMIDE AND THEIR USING AS INHIBITORS OF TYROSINE KINASE VEGF RECEPTORS | 2001 |
|
RU2296124C2 |
APPLICATION OF PYRIMIDYLAMINOBENZAMIDES FOR TREATMENT OF DISEASES SENSITIVE TO MODULATION OF KINASE Tie-2 ACTIVITY | 2006 |
|
RU2404776C2 |
2-(PHENYL OR PYRID-3-YL)AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF LEUCINE-RICH REPEATING KINASE 2 (LRRK2) FOR TREATMENT OF PARKINSON'S DISEASE | 2012 |
|
RU2647849C2 |
USE OF PYRIMIDYLAMINOBENZAMIDE DERIVATIVES FOR TREATING SYSTEMIC MASTOCYTOSIS | 2006 |
|
RU2445960C2 |
Authors
Dates
2012-03-10—Published
2006-06-07—Filed